Literature DB >> 12023121

In vitro selection as a powerful tool for the applied evolution of proteins and peptides.

William J Dower1, Larry C Mattheakis.   

Abstract

New in vitro methods for the applied evolution of protein structure and function complement conventional cellular and phage-based methods. Strategies employing the direct physical linkage of genotype and phenotype, and the compartmental association of gene and product to select desired properties are discussed, and recent useful applications are described. Engineering of antibodies and other proteins, selection from cDNA libraries, and the creation of functional protein domains from completely random starting sequences illustrate the value of the in vitro approaches. Also discussed is an emerging new direction for in vitro display technology: the self-assembly of protein arrays.

Mesh:

Substances:

Year:  2002        PMID: 12023121     DOI: 10.1016/s1367-5931(02)00332-0

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  12 in total

1.  Programming peptidomimetic syntheses by translating genetic codes designed de novo.

Authors:  Anthony C Forster; Zhongping Tan; Madhavi N L Nalam; Hening Lin; Hui Qu; Virginia W Cornish; Stephen C Blacklow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

2.  DNA display for in vitro selection of diverse peptide libraries.

Authors:  Masato Yonezawa; Nobuhide Doi; Yuko Kawahashi; Toru Higashinakagawa; Hiroshi Yanagawa
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

3.  Turning G proteins on and off using peptide ligands.

Authors:  William W Ja; Ofer Wiser; Ryan J Austin; Lily Y Jan; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2006-10-24       Impact factor: 5.100

Review 4.  State-selective binding peptides for heterotrimeric G-protein subunits: novel tools for investigating G-protein signaling dynamics.

Authors:  Christopher A Johnston; Francis S Willard; J Kevin Ramer; Rainer Blaesius; C Natalia Roques; David P Siderovski
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

5.  Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display.

Authors:  Fang Chen; Yinglan Zhao; Min Liu; Dongqing Li; Hongyan Wu; Haidan Chen; Yongzhe Zhu; Fengling Luo; Jin Zhong; Yidan Zhou; Zhongtian Qi; Xiao-Lian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

6.  MutS-mediated enrichment of mutated DNA produced by directed evolution in vitro.

Authors:  Tianying Zhong; Yafeng Zhou; Lijun Bi; Xian-En Zhang
Journal:  World J Microbiol Biotechnol       Date:  2010-10-10       Impact factor: 3.312

7.  Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.

Authors:  Oliver Hartley; Hubert Gaertner; Jill Wilken; Darren Thompson; Richard Fish; Alejandra Ramos; Cristina Pastore; Brigitte Dufour; Fabrice Cerini; Astrid Melotti; Nikolaus Heveker; Laurent Picard; Marc Alizon; Donald Mosier; Stephen Kent; Robin Offord
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-15       Impact factor: 11.205

8.  The fission yeast pleckstrin homology domain protein Spo7 is essential for initiation of forespore membrane assembly and spore morphogenesis.

Authors:  Michiko Nakamura-Kubo; Aiko Hirata; Chikashi Shimoda; Taro Nakamura
Journal:  Mol Biol Cell       Date:  2011-07-20       Impact factor: 4.138

9.  DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells.

Authors:  Nobuhide Doi; Natsuko Yamakawa; Hideaki Matsumoto; Yasutsugu Yamamoto; Tetsuya Nagano; Nobutaka Matsumura; Kenichi Horisawa; Hiroshi Yanagawa
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

10.  Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale.

Authors:  Fernanda C Cardoso; Joanne S Roddick; Penny Groves; Denise L Doolan
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.